Quite frankly Platinum I can see Wayne looking for a big acquisition deal rather than develop this all the way to market . Admedus has been there before and the cost involved to market the TAVR against the big boys is enormous . Then take into account is the FDA going to cooperate with AVR knowing that their intentions is retaining the TAVR and being in direct opposition to the two biggest TAVR manufacturers ( both US companies ) . No WP is a smart operator with decades of experience in maters involving the FDA . I can see a great acquisition deal being struck before AVR even gets to deep into the FDA trial GLTATH
outstanding results ., page-9
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.68 |
Change
0.680(4.53%) |
Mkt cap ! $331.4M | |||
| Open | High | Low | Value | Volume |
| $14.90 | $15.75 | $14.85 | $431.9K | 28.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 200 | $15.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.95 | 300 | 1 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |